News

Medical Device Network on MSN4d
Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) ...
HME News1d
Studies link Abbott CGM with reduced hospitalizations
Abbott’s FreeStyle Libre continuous glucose monitoring technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes, according ...
Drug Delivery Business5d
Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.
Pharmabiz3d
Abbott's Libre technology is first CGM associated with reduced hospitalizations for heart complications in people with diabetes
Abbott announced results from its REFLECT real-world studies that show the use of FreeStyle Libre continuous glucose monitoring (CGM) technology is associated with a significant reduction in the risk ...
BioWorld5d
Abbott studies show CGM users have fewer hospitalizations
A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces ...
Nasdaq5d
Abbott Announces New Positive Data From REFLECT Studies Of FreeStyle Libre CGM
(RTTNews) - Abbott Laboratories (ABT) Thursday announced positive data from REFLECT studies of its FreeStyle Libre continuous glucose monitoring (CGM) technology. The REFLECT studies, funded by ...
Seeking Alpha21d
Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
April 29, 2025 /PRNewswire/ -- Abbott (ABT), the global leader in continuous glucose monitoring (CGM ... with the outside US version of the FreeStyle Libre 14 day system. Data is applicable ...